Annual Cash & Cash Equivalents
$143.19 M
+$603.00 K+0.42%
December 31, 2023
Summary
- As of February 8, 2025, IOBT annual cash & cash equivalents is $143.19 million, with the most recent change of +$603.00 thousand (+0.42%) on December 31, 2023.
- During the last 3 years, IOBT annual cash & cash equivalents has risen by +$139.79 million (+4105.37%).
- IOBT annual cash & cash equivalents is now -32.31% below its all-time high of $211.53 million, reached on December 31, 2021.
Performance
IOBT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$80.19 M
-$20.56 M-20.41%
September 30, 2024
Summary
- As of February 8, 2025, IOBT quarterly cash and cash equivalents is $80.19 million, with the most recent change of -$20.56 million (-20.41%) on September 30, 2024.
- Over the past year, IOBT quarterly cash and cash equivalents has dropped by -$37.80 million (-32.04%).
- IOBT quarterly cash and cash equivalents is now -62.09% below its all-time high of $211.53 million, reached on December 31, 2021.
Performance
IOBT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IOBT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.4% | -32.0% |
| 3 y3 years | +4105.4% | -32.0% |
| 5 y5 years | +1725.0% | -32.0% |
IOBT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.3% | +0.4% | -62.1% | at low |
| 5 y | 5-year | -32.3% | +4105.4% | -62.1% | +2254.9% |
| alltime | all time | -32.3% | +4105.4% | -62.1% | +2254.9% |
IO Biotech Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $80.19 M(-20.4%) |
| Jun 2024 | - | $100.75 M(-14.6%) |
| Mar 2024 | - | $117.98 M(-17.6%) |
| Dec 2023 | $143.19 M(+0.4%) | $143.19 M(-13.5%) |
| Sep 2023 | - | $165.50 M(+50.3%) |
| Jun 2023 | - | $110.09 M(-14.3%) |
| Mar 2023 | - | $128.53 M(-9.9%) |
| Dec 2022 | $142.59 M | $142.59 M(-5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $151.17 M(-11.1%) |
| Jun 2022 | - | $170.12 M(-9.5%) |
| Mar 2022 | - | $187.90 M(-11.2%) |
| Dec 2021 | $211.53 M(+6112.4%) | $211.53 M(+365.1%) |
| Sep 2021 | - | $45.48 M(-16.9%) |
| Jun 2021 | - | $54.75 M(+1508.0%) |
| Dec 2020 | $3.40 M(-56.6%) | $3.40 M |
| Dec 2019 | $7.85 M | - |
FAQ
- What is IO Biotech annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for IO Biotech?
- What is IO Biotech annual cash & cash equivalents year-on-year change?
- What is IO Biotech quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for IO Biotech?
- What is IO Biotech quarterly cash and cash equivalents year-on-year change?
What is IO Biotech annual cash & cash equivalents?
The current annual cash & cash equivalents of IOBT is $143.19 M
What is the all time high annual cash & cash equivalents for IO Biotech?
IO Biotech all-time high annual cash & cash equivalents is $211.53 M
What is IO Biotech annual cash & cash equivalents year-on-year change?
Over the past year, IOBT annual cash & cash equivalents has changed by +$603.00 K (+0.42%)
What is IO Biotech quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IOBT is $80.19 M
What is the all time high quarterly cash and cash equivalents for IO Biotech?
IO Biotech all-time high quarterly cash and cash equivalents is $211.53 M
What is IO Biotech quarterly cash and cash equivalents year-on-year change?
Over the past year, IOBT quarterly cash and cash equivalents has changed by -$37.80 M (-32.04%)